North America Urinary Tract Infection Testing Market Size, Share & Trends Analysis Report By Type (Urethritis, Cystitis, Pyelonephritis), By Product, By End-use (Reference Laboratories, General Practitioners), By Country, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation and Scope
                       1.1.1. Segment Definitions
                           1.1.1.1. Type segment
                           1.1.1.2. Product segment
                           1.1.1.3. End-user segment
                   1.2. Regional Scope
                   1.3. Estimates and Forecast Timeline
                   1.4. Objectives
                       1.4.1. Objective - 1
                       1.4.2. Objective - 2
                       1.4.3. Objective - 3
                   1.5. Research Methodology
                   1.6. Information Procurement
                       1.6.1. Purchased Database
                       1.6.2. GVR’s Internal Database
                       1.6.3. Secondary Sources
                       1.6.4. Primary research
                   1.7. Information or Data Analysis
                       1.7.1. Data Analysis Models
                   1.8. Market Formulation & Validation
                   1.9. Model Details
                       1.9.1. Commodity Flow Analysis
                   1.10. List of Secondary Sources
                   1.11. List of Abbreviations
Chapter 2. Executive Summary
                   2.1. Market Snapshot
                   2.2. Product and Type Snapshot
                   2.3. End-use Snapshot
                   2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent Market Outlook
                       3.1.2. Related/Ancillary Market Outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                           3.2.1.1. Increasing prevalence of urinary tract infections (UTIs)
                           3.2.1.2. Technological Advancements in Urinary Tract Infection Testing
                           3.2.1.3. Growing prevalence of catheter-associated UTIs (CAUTIs)
                       3.2.2. Market Restraint Analysis
                           3.2.2.1. High cost associated with advanced UTI testing technologies.
                   3.3. Industry Analysis Tools
                       3.3.1. Porter’s Five Forces Analysis
                       3.3.2. PESTEL Analysis
                       3.3.3. COVID-19 Impact Analysis
Chapter 4. North America Urinary Tract Infection Testing Market: Type Analysis
                   4.1. North America Urinary Tract Infection Testing Market: Type Movement Analysis
                   4.2. Urethritis
                       4.2.1. Urethritis Market, 2018 - 2030 (USD Million)
                   4.3. Cystitis
                       4.3.1. Cystitis Market, 2018 - 2030 (USD Million)
                   4.4. Pyelonephritis
                       4.4.1. Pyelonephritis Market, 2018 - 2030 (USD Million)
Chapter 5. North America Urinary Tract Infection Testing Market: Product Analysis
                   5.1. North America Urinary Tract Infection Testing Market: Product Movement Analysis
                   5.2. Instruments
                       5.2.1. Instruments Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
                   5.3. Consumables
                       5.3.1. Consumables Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
Chapter 6. North America Urinary Tract Infection Testing Market: End-use Analysis
                   6.1. North America Urinary Tract Infection Testing Market: End-use Movement Analysis
                   6.2. General Practitioners
                       6.2.1. General Practitioners Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
                   6.3. Urologists
                       6.3.1. Urologists Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
                   6.4. Urogynecologists
                       6.4.1. Urogynecologists Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
                   6.5. Hospital Laboratories
                       6.5.1. Hospital Laboratories Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
                   6.6. Reference Laboratories
                       6.6.1. Reference Laboratories Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
                   6.7. Hospital Emergency Departments
                       6.7.1. Hospital Emergency Departments Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
                   6.8. Urgent Care
                       6.8.1. Urgent Care Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
                   6.9. Others
                       6.9.1. Others Market, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
Chapter 7. North America Urinary Tract Infection Testing Market: Regional Analysis
                   7.1. North America
                       7.1.1. SWOT Analysis
                       7.1.2. North America Urinary Tract Infection Testing Market, 2018 - 2030 (USD Million)
                       7.1.3. U.S.
                           7.1.3.1. Key Country Dynamics
                           7.1.3.2. Target Disease Prevalence
                           7.1.3.3. Competitive Scenario
                           7.1.3.4. Regulatory Framework
                           7.1.3.5. U.S. Urinary Tract Infection Testing Market, 2018 - 2030 (USD Million)
                       7.1.4. Canada
                           7.1.4.1. Key Country Dynamics
                           7.1.4.2. Target Disease Prevalence
                           7.1.4.3. Competitive Scenario
                           7.1.4.4. Regulatory Framework
                           7.1.4.5. Canada Urinary Tract Infection Testing Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                   8.1. Participant Categorization
                       8.1.1. QIAGEN
                           8.1.1.1. Overview
                           8.1.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           8.1.1.3. Product Benchmarking
                           8.1.1.4. Strategic Initiatives
                       8.1.2. Accelerate Diagnostics, Inc.
                           8.1.2.1. Overview
                           8.1.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           8.1.2.3. Product Benchmarking
                           8.1.2.4. Strategic Initiatives
                       8.1.3. Bio-Rad Laboratories, Inc.
                           8.1.3.1. Overview
                           8.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           8.1.3.3. Product Benchmarking
                           8.1.3.4. Strategic Initiatives
                       8.1.4. F. Hoffmann-La Roche Ltd.
                           8.1.4.1. Overview
                           8.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           8.1.4.3. Product Benchmarking
                           8.1.4.4. Strategic Initiatives
                       8.1.5. Danaher Corporation
                           8.1.5.1. Overview
                           8.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           8.1.5.3. Product Benchmarking
                           8.1.5.4. Strategic Initiatives
                       8.1.6. Siemens Healthcare GmbH
                           8.1.6.1. Overview
                           8.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           8.1.6.3. Product Benchmarking
                           8.1.6.4. Strategic Initiatives
                       8.1.7. Randox Laboratories Ltd.
                           8.1.7.1. Overview
                           8.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           8.1.7.3. Product Benchmarking
                           8.1.7.4. Strategic Initiatives
                       8.1.8. Thermo Fisher Scientific, Inc.
                           8.1.8.1. Overview
                           8.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           8.1.8.3. Product Benchmarking
                           8.1.8.4. Strategic Initiatives
                       8.1.9. bioMérieux SA
                           8.1.9.1. Overview
                           8.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           8.1.9.3. Product Benchmarking
                           8.1.9.4. Strategic Initiatives
                       8.1.10. T2 Biosystems, Inc.
                           8.1.10.1. Overview
                           8.1.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
                           8.1.10.3. Product Benchmarking
                           8.1.10.4. Strategic Initiatives
                   8.2. Participant’s Overview
                   8.3. Financial Performance
                   8.4. Product Benchmarking
                   8.5. Company Market Share Analysis, 2022
                   8.6. Strategy Mapping
                       8.6.1. Expansions
                       8.6.2. Acquisitions
                       8.6.3. Product/Service Launches
                       8.6.4. Others
Chapter 9. Conclusion/Analyst Perspective

List of Tables

1. List of Secondary Sources
2. List of Abbreviations
3. North America Urinary Tract Infection Testing Market, By Country, 2018 - 2030 (USD Million)
4. North America Urinary Tract Infection Testing Market, By Type, 2018 - 2030 (USD Million)
5. North America Urinary Tract Infection Testing Market, By Product, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
6. North America Urinary Tract Infection Testing Market, by End - use, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
7. U.S. Urinary Tract Infection Testing Market, by Type, 2018 - 2030 (USD Million)
8. U.S. Urinary Tract Infection Testing Market, By Product, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
9. U.S. Urinary Tract Infection Testing Market, by End - use, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
10. Canada Urinary Tract Infection Testing Market, by Type, 2018 - 2030 (USD Million)
11. Canada Urinary Tract Infection Testing Market, By Product, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
12. Canada Urinary Tract Infection Testing Market, by End - use, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)

List of Figures

1. Market research process
2. Information procurement
3. Primary research pattern
4. Market research approaches
5. Value chain - based sizing & forecasting
6. Market formulation & validation
7. North America urinary tract infection testing: Market segmentation
8. Market snapshot, 2022
9. Market Trends & Outlook
10. Market driver relevance analysis (current & future impact)
11. Market restraint relevance analysis (current & future impact)
12. Market challenge relevance analysis (current & future impact)
13. SWOT analysis
14. Porter’s five forces analysis
15. North America urinary tract infection testing market: Type outlook and key takeaways
16. North America urinary tract infection testing market: Type movement analysis & market share, 2022 & 2030
17. Urethritis market estimates and forecast, 2018 - 2030 (USD Million)
18. Cystitis market estimates and forecast, 2018 - 2030 (USD Million)
19. Pyelonephritis market estimates and forecast, 2018 - 2030 (USD Million)
20. North America urinary tract infection testing market: Product outlook and key takeaways
21. North America urinary tract infection testing market: Product movement analysis & market share, 2022 & 2030
22. Instruments market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
23. Consumables market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
24. North America urinary tract infection testing market: End - use outlook and key takeaways
25. North America urinary tract infection testing market: End - use movement analysis & market share, 2022 & 2030
26. General practitioners market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
27. Urologists market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
28. Urogynecologists market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
29. Hospital laboratories market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
30. Reference laboratories market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
31. Hospital emergency departments market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
32. Urgent care market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
33. Others market estimates and forecast, 2018 - 2030 (Revenue, USD Million; Volume, Units, 2018 - 2030)
34. Regional marketplace: key takeaways
35. Regional outlook, 2022 & 2030
36. North America urinary tract infection testing market: region movement analysis.
37. North America urinary tract infection testing market, 2018 - 2030 (Revenue, USD Million, 2018 - 2030)
38. U.S. key country dynamics
39. U.S. urinary tract infection testing market, 2018 - 2030 (Revenue, USD Million, 2018 - 2030)
40. Canada key country dynamics
41. Canada urinary tract infection testing market, 2018 - 2030 (Revenue, USD Million, 2018 - 2030)